You are here

Evaluation Of Acceptability And Satisfaction Of Hemophilia Patients Treated With FusENGO

Last updated on March 14, 2019

FOR MORE INFORMATION
Study Location
Istituto di Ematologia
Roma, Lazio, 00161 Italy
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Hemophilia A
Sex
Male
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18-65 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Male adults (aged 18 to 65 years) with Haemophilia A (all severity levels) who
currently use FVIII treatment either prophylactically or on-demand using traditional
factor VIII delivery mechanisms.

- Patients advised for any reason by their physician to switch to a new factor VIII
delivery device, namely FuseNGO, before receiving any details about this study or
Patients who requested to be treated with a new factor VIII delivery device namely
FuseNGO, before receiving any details about this study.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Patients not previously recommended by their physician to switch to this new factor
VIII delivery system or Patients who did not previously ask their physician to be
switched to this new factor VIII delivery system.

- Patients for which it is anticipated that 10 infusions will not occur in the 12 months
following their inclusion in the study.

NCT01959919
Pfizer
Completed
Evaluation Of Acceptability And Satisfaction Of Hemophilia Patients Treated With FusENGO

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Hemophilia A or B
NCT03363321
Males
12+
Years
Multiple Sites

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now